Biotechnology Stocks I Performance Guide: Mirum Pharmaceuticals, Inc. (MIRM)
MIRM has no dividends
Table and Chart of MIRM Performance
See what a $1,000 investment in MIRM is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| MIRM Returns | |
|---|---|
| Start Date | Aug-30-2019 |
| Start Price | $12.69 |
| End Date | Dec-01-2023 |
| End Price | $32.00 |
| # Prices | 53 |
| Min Date | Oct-31-2019 |
| Min Price | $7.18 |
| Max Date | Nov-30-2023 |
| Max Price | $32.07 |
| Total Return | 152.17% |
| Annualized Return | 23.30% |
| Current Value of $1,000 Purchase | $2,522 |
| Number Returns | 1,378 |
| Average Return | 39.48% |
| Number Profitable Returns | 1,084 |
| Percent Profitable Returns | 78.66% |
| Number Unprofitable Returns | 294 |
| Percent Unprofitable Returns | 21.34% |
| Profitable to Unprofitable Returns Ratio | 3.69 |
| MIRM Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $1,491,658,000 | Price to Sales | 10.31 |
| Earnings per Share | $-4.2700 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | 5.54 |
| PRICE DATA | |
| 52 Week High | $33.39 |
| 52 Week Low | $17.49 |
| Analyst Target Price | $54.7 |
| 50-Day Moving Average | $29.8 |
| 200-Day Moving Average | $27.0 |
| FINANCIAL DATA | |
| Revenue per Share | $3.763 |
| Revenue | $144,726,000 |
| Profit Margin | -113.5% |
| Return on Equity | -0.749% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
MIRM Compare Returns with S&P 500
MIRM Trendline Chart